Innovation
Australian innovation pilot aims to reduce cost of vaccination in developing world
GSK has invested $7.7 million in a new pilot vaccine facility with the hope Australian manufacturing innovation could reduce cost of vaccination in developing world.
Access to healthcare
Increasing medicine access across the world's poorest nations
GSK expands graduated approach to patents and intellectual property to widen access to medicines in the world’s poorest countries.
Innovation
Bioelectronics
GSK's Bioelectronics R&D unit is pursuing a relatively new scientific field that could one day result in a new class of medicines that would not be pills or injections but miniaturised, implantable devices.
How we do business
PharmAus 2017: Showcasing the health and economic benefits of innovation in medicines
The inaugural PharmAus showcase saw GSK and 19 other innovative pharmaceutical companies illustrate our industry’s investment and collaboration with Australia’s top research institutes, universities, biotechs and patients, to deliver the latest breakthroughs in treatment.
Our people
Isaac Barr
Isaac Barr joined GSK as a chemical engineer graduate in 2015. Here he talks about his first year at our Boronia manufacturing plant supporting the team to build a new pilot vaccine facility.
Our people
Philip Leslie
Philip Leslie leads innovation at GSK's manufacturing site in Boronia. He was recognised at the 2017 Victorian Manufacturing Awards as a Hall of Fame honoree.